Erasca (ERAS) Other Operating Expenses (2020 - 2026)

Erasca's (ERAS) quarterly Other Operating Expenses came in at $150.0 million in Q1 2026, up 7400.0% on a QoQ basis from $2.0 million in Q3 2025.

Erasca (ERAS) Other Operating Expenses (2020 - 2026) Analysis & Trends

Erasca (ERAS) has 6 years of Other Operating Expenses data on file, last reported at $150.0 million in Q1 2026.

Quarterly Other Operating Expenses changed N/A year-over-year to $150.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.5 million (up 608.89% YoY) and the FY2025 annual result came in at $9.5 million, down 57.78% from the prior year.
Other Operating Expenses rose to $150.0 million in Q1 2026, from $2.0 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $150.0 million in Q1 2026 to a low of $2.0 million in Q1 2022.
A 4-year average of $47.3 million and a median of $15.0 million in 2024 frame the typical range for Other Operating Expenses.
Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 45.65% — and 2025, when it slumped 66.67%.
Tracing ERAS's Other Operating Expenses over 4 years: stood at $100.0 million in 2022, then slumped by 77.5% to $22.5 million in 2024, then sank by 91.11% to $2.0 million in 2025, then soared by 7400.0% to $150.0 million in 2026.
The last three Other Operating Expenses figures came in at $150.0 million (Q1 2026), $2.0 million (Q3 2025), and $7.5 million (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Erasca	6.43 Bn	6.16 Bn	-

Download Data